NGM Biopharmaceuticals (NGM) Short Interest Ratio & Short Volume → Claim Your FREE 'AI Income Playbook' Now! (From The Oxford Club) (Ad) Free NGM Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsEarningsHeadlinesInsider TradesOwnershipShort InterestSustainabilityTrends NGM Biopharmaceuticals Short Interest DataCurrent Short Interest2,390,000 sharesPrevious Short Interest1,680,000 sharesChange Vs. Previous Month+42.26%Dollar Volume Sold Short$3.80 millionShort Interest Ratio2.2 Days to CoverLast Record DateMarch 31, 2024Outstanding Shares83,462,000 sharesFloat Size52,820,000 sharesShort Percent of Float4.52%Today's Trading Volume2,390,800 sharesAverage Trading Volume1,467,160 sharesToday's Volume Vs. Average163% Short Selling NGM Biopharmaceuticals ? Sign up to receive the latest short interest report for NGM Biopharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNGM Short Interest Over TimeNGM Days to Cover Over TimeNGM Percentage of Float Shorted Over Time Ad The Oxford ClubYour "AI Income Playbook" Awaits...Today, he wants to give you his "AI Income Playbook"... FREE of charge! Inside, you'll discover Marc's favorite AI dividend stocks... Complete with their names, ticker symbols, and full breakdown of their massive income potential.Click here now to claim your FREE copy of Marc's AI playbook. NGM Biopharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20242,390,000 shares $3.80 million +42.3%4.5%2.2 $1.59 3/15/20241,680,000 shares $2.64 million +3.1%3.2%1.2 $1.57 2/29/20241,630,000 shares $2.48 million -1.8%3.1%1.3 $1.52 2/15/20241,660,000 shares $2.47 million -1.2%3.7%1.4 $1.49 1/31/20241,680,000 shares $2.57 million +9.1%4.1%1.7 $1.53 1/15/20241,540,000 shares $2.16 million -6.1%3.8%1.6 $1.40 Get the Latest News and Ratings for NGM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NGM Biopharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/31/20231,640,000 shares $1.41 million -34.4%4.0%1.7 $0.86 12/15/20232,500,000 shares $1.88 million -1.6%5.6%5.4 $0.75 11/30/20232,540,000 shares $1.90 million -2.3%5.7%5.4 $0.75 11/15/20232,600,000 shares $1.77 million -2.3%5.8%5.1 $0.68 10/31/20232,660,000 shares $2.26 million +4.7%6.0%5.9 $0.85 10/15/20232,540,000 shares $2.90 million +3.7%5.7%5.8 $1.14 9/30/20232,450,000 shares $2.62 million +2.9%6.0%6.9 $1.07 9/15/20232,380,000 shares $3.12 million -5.6%5.3%7 $1.31 8/31/20232,520,000 shares $4.76 million -17.9%5.7%7.4 $1.89 8/15/20233,070,000 shares $6.29 million -6.1%6.9%9.7 $2.05 7/31/20233,270,000 shares $7.75 million -1.2%7.3%10.3 $2.37 7/15/20233,310,000 shares $9.20 million +4.1%7.7%10.3 $2.78 6/30/20233,180,000 shares $8.24 million -7.6%7.4%9.8 $2.59 6/15/20233,440,000 shares $12.18 million +7.2%8.0%10.9 $3.54 5/31/20233,210,000 shares $9.73 million -8.0%7.5%10.5 $3.03 5/15/20233,490,000 shares $11.62 million -7.4%8.4%11.6 $3.33 4/30/20233,770,000 shares $17.00 million +2.5%6.0%12.5 $4.51 4/15/20233,680,000 shares $13.25 million No Change5.9%11.8 $3.60 3/31/20233,680,000 shares $15.01 million +7.6%9.8%11.2 $4.08 3/15/20233,420,000 shares $13.00 million +10.7%9.1%9.9 $3.80 2/28/20233,090,000 shares $14.65 million +3.0%8.2%9 $4.74 2/15/20233,000,000 shares $14.10 million -3.2%7.9%8.3 $4.70 1/31/20233,100,000 shares $16.24 million +28.6%8.1%7.7 $5.24 1/15/20232,410,000 shares $12.77 million +13.7%6.3%3.7 $5.30 12/30/20222,120,000 shares $10.64 million +2.4%5.4%2.3 $5.02 12/15/20222,070,000 shares $10.78 million -16.9%5.3%2.2 $5.21 11/30/20222,490,000 shares $13.77 million +12.2%6.5%2.6 $5.53 11/15/20222,220,000 shares $12.32 million +2.8%5.8%2.3 $5.55 10/31/20222,160,000 shares $11.53 million -25.5%5.6%2.3 $5.34 10/15/20222,900,000 shares $33.50 million +8.6%7.5%3.3 $11.55 9/30/20222,670,000 shares $34.92 million +23.0%6.9%6.1 $13.08 9/15/20222,170,000 shares $33.48 million -6.5%6.8%4.6 $15.43 8/31/20222,320,000 shares $32.74 million -3.7%7.4%4.9 $14.11 8/15/20222,410,000 shares $42.49 million -4.4%7.7%5.2 $17.63America's #1 AI Dividend Stock Revealed (Ad)Income expert Marc Lichtenfeld has a special gift reserved just for you... It's his brand-new "AI Income Playbook" - and it's yours FREE!Click here now to claim your FREE copy of Marc's AI playbook. 7/31/20222,520,000 shares $36.49 million -1.6%8.5%5.3 $14.48 7/15/20222,560,000 shares $39.88 million -3.8%9.9%5.4 $15.58 6/30/20222,660,000 shares $34.10 million +23.2%10.3%6.1 $12.82 6/15/20222,160,000 shares $28.12 million +6.9%8.4%5.2 $13.02 5/31/20222,020,000 shares $27.96 million +2.5%9.1%5.4 $13.84 5/15/20221,970,000 shares $23.46 million +7.7%8.1%6.4 $11.91 4/30/20221,830,000 shares $22.84 million +2.8%7.4%6.7 $12.48 4/15/20221,780,000 shares $27.41 million -16.4%7.2%7 $15.40 3/31/20222,130,000 shares $32.48 million -12.7%N/A8.1 $15.25 3/15/20222,440,000 shares $33.70 million -1.2%N/A9.7 $13.81 2/28/20222,470,000 shares $36.70 million -0.4%10.1%8.8 $14.86 2/15/20222,480,000 shares $40.37 million +4.6%10.2%8.6 $16.28 1/31/20222,370,000 shares $37.47 million +28.8%9.8%7.8 $15.81 1/15/20221,840,000 shares $29.37 million +4.6%7.2%6.1 $15.96 12/31/20211,760,000 shares $31.17 million +27.5%6.9%6 $17.71 12/15/20211,380,000 shares $25.56 million +4.6%5.4%4.3 $18.52 11/30/20211,320,000 shares $23.79 million +10.9%5.2%3.9 $18.02 11/15/20211,190,000 shares $23.73 million +16.7%4.7%3.5 $19.94 10/29/20211,020,000 shares $18.84 million +13.8%4.0%3 $18.47 10/15/2021896,600 shares $17.65 million +13.8%3.5%2.4 $19.68 9/30/2021788,100 shares $16.57 million +5.7%3.1%2.2 $21.02 9/15/2021745,300 shares $19.11 million +7.4%2.9%2 $25.64 8/31/2021693,800 shares $15.15 million +15.7%2.7%1.9 $21.83 8/13/2021599,800 shares $13.63 million -58.9%2.4%1.2 $22.73 7/30/20211,460,000 shares $29.77 million -2.7%5.8%2.9 $20.39 7/15/20211,500,000 shares $31.40 million -28.2%6.0%3.4 $20.93 6/30/20212,090,000 shares $41.21 million -15.4%8.4%4.8 $19.72 6/15/20212,470,000 shares $47.47 million +87.1%9.9%6.3 $19.22 5/28/20211,320,000 shares $19.88 million -28.3%5.3%3.8 $15.06 5/14/20211,840,000 shares $51.48 million -8.9%7.4%6.2 $27.98 4/30/20212,020,000 shares $56.92 million No Change8.1%9.8 $28.18 4/15/20212,020,000 shares $52.12 million +3.6%8.2%9.2 $25.80 3/31/20211,950,000 shares $54.37 million -9.3%8.7%7.6 $27.88 3/15/20212,150,000 shares $62.59 million +25.0%9.5%6.9 $29.11 2/26/20211,720,000 shares $44.15 million -7.0%28.0%5.6 $25.67 2/12/20211,850,000 shares $53.67 million +8.2%30.3%6.6 $29.01 1/29/20211,710,000 shares $44.12 million -2.3%9.5%6.3 $25.80 1/15/20211,750,000 shares $45.31 million -38.4%9.7%6.6 $25.89 12/31/20202,840,000 shares $87.39 million -23.0%15.7%11.4 $30.77 12/15/20203,690,000 shares $101.88 million -0.5%21.7%22.5 $27.61 11/30/20203,710,000 shares $88.48 million -4.9%22.0%25.4 $23.85 11/15/20203,900,000 shares $79.95 million -2.3%23.1%24 $20.50 10/30/20203,990,000 shares $68.95 million -1.5%23.7%25.1 $17.28 10/15/20204,050,000 shares $67.31 million -0.3%24.6%25.6 $16.62 9/30/20204,060,000 shares $64.59 million -1.9%24.7%24.1 $15.91 9/15/20204,140,000 shares $77.87 million +3.2%25.1%20.5 $18.81 NGM Short Interest - Frequently Asked Questions What is NGM Biopharmaceuticals' current short interest? Short interest is the volume of NGM Biopharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 2,390,000 shares of NGM short. 4.52% of NGM Biopharmaceuticals' shares are currently sold short. Learn More on NGM Biopharmaceuticals' current short interest. What is a good short interest ratio for NGM Biopharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NGM shares currently have a short interest ratio of 2.0. Learn More on NGM Biopharmaceuticals's short interest ratio. What is a good short interest percentage for NGM Biopharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.52% of NGM Biopharmaceuticals' floating shares are currently sold short. Is NGM Biopharmaceuticals' short interest increasing or decreasing? NGM Biopharmaceuticals saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 2,390,000 shares, an increase of 42.3% from the previous total of 1,680,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is NGM Biopharmaceuticals' float size? NGM Biopharmaceuticals currently has issued a total of 83,462,000 shares. Some of NGM Biopharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. NGM Biopharmaceuticals currently has a public float of 52,820,000 shares. How does NGM Biopharmaceuticals' short interest compare to its competitors? 4.52% of NGM Biopharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to NGM Biopharmaceuticals: LianBio (0.36%), PHAXIAM Therapeutics S.A. (0.01%), CymaBay Therapeutics, Inc. (5.10%), Bristol-Myers Squibb (1.42%), Amgen Inc. (1.69%), and AstraZeneca PLC (0.22%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short NGM Biopharmaceuticals stock? Short selling NGM is an investing strategy that aims to generate trading profit from NGM Biopharmaceuticals as its price is falling. NGM shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NGM Biopharmaceuticals? A short squeeze for NGM Biopharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NGM, which in turn drives the price of the stock up even further. How often is NGM Biopharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NGM, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: LianBio Short Squeeze PHAXIAM Therapeutics Short Squeeze 180 Life Sciences Short Squeeze Alpha Tau Medical Short Squeeze Apollomics Short Squeeze Artelo Biosciences Short Squeeze BriaCell Therapeutics Short Squeeze Cardio Diagnostics Short Squeeze Carmell Short Squeeze Cassava Sciences Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:NGM) was last updated on 6/15/2024 by MarketBeat.com Staff From Our PartnersGold Set to EXPLODE!The perfect storm is brewing to drive gold's price through the roof! And our weakening dollars are causing ...Gold Safe Exchange | SponsoredJeff Bezos & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Con...InvestorPlace | SponsoredCollect 10%+ Dividends from AI's Explosive Growth?What if I told you there was a way to collect double-digit income from the AI revolution... Without having ...The Oxford Club | SponsoredTiny, One-Half Inch Pellet the Key to INFINITE Energy?It’s a tiny, $1 billion company that holds the key to this power. And yet, it’s the largest company of its ...Eagle Publishing | SponsoredBiden’s Tax Plan Could Destroy Your Retirement Savings!Leading economists are issuing stark warnings: The anticipated capital gains tax increase under President B...GoldenCrest Metals | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NGM Biopharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NGM Biopharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.